UX003 rhGUS enzyme replacement therapy

recombinant human beta-glucuronidase

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UX003 rhGUS enzyme replacement therapy, covering 2017-02-06 to 2017-02-06. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient